80 likes | 213 Views
Supplemental Figure 1. A B. C. Supplemental Figure 2. RWPE-1. DU-145. AR- CaP -M. PC-3. AR- CaP -E. PC-3-ML. 70 kDa. c- myc. 57 kDa. β-actin. 42 kDa. Supplemental Figure 3. A B. Supplemental Figure 4. pPEG -Luc. pAEG -Luc. 24h 48h.
E N D
Supplemental Figure 2 RWPE-1 DU-145 AR-CaP-M PC-3 AR-CaP-E PC-3-ML 70 kDa c-myc 57 kDa β-actin 42 kDa
Supplemental Figure 4 pPEG-Luc pAEG-Luc 24h 48h 24h 48h D V L R D V L R D V L R D V L R PC3-ML PCa-1 PC3-ML PCa-2 PC3-ML PCa-3 PC3-ML PCa-1 PC3-ML PCa-2 PC3-ML PCa-3 PC3-ML PCa-4 Control Ctrl-1 Control Ctrl-2 Control Ctrl-3 Control Ctrl-1 Control Ctrl-2 Control Ctrl-3
Supplemental Figure 5 NS (Normalized ng Luc pDNA)/(100ng gDNA) AEG-Prom treated PCa Lungs Tumor PEG-Prom treated PCa Lungs Tumor
Supplemental Figure 6 Ex-vivo BLI In-vivo BLI Gross H&E IHC(Anti-Luc) Pathology A B C D E T
Supplemental Figure 7 A B PC3-ML PCa-1 PC3-ML PCa-2 PC3-ML PCa-3 Control Ctrl-1 Control Ctrl-2 Control Ctrl-3
Supplemental Figure 8 B A L2 L2 L1 L2 L5 L3, L4 C